Adds Medicare Part B coverage for defined "pharmacist services," letting pharmacists bill Medicare for certain testing and treatment visits (including COVID‑19, influenza, RSV, and strep throat) and other services tied to declared public health emergencies. The change sets payment and balance-billing rules, defines how pharmacists must collaborate with physicians or other practitioners, and applies to items and services furnished on or after 2026-01-01.